World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Yamamoto-Furusho JK. Genetic factors associated with the development of inflammatory bowel disease. World J Gastroenterol 2007; 13(42): 5594-5597 [PMID: 17948933 DOI: 10.3748/wjg.v13.i42.5594]
URL:	https://www.wjgnet.com/1007-9327/full/v13/i42/5594.htm

(0) (0) (0) (3017) (27)

Number	Citing Articles
1	Masayoshi Onuki, Masaki Watanabe, Narumi Ishihara, Koichiro Suzuki, Kei Takizawa, Masato Hirota, Takahiro Yamada, Aiko Egawa, Osamu Shibahara, Midori Nishii, Michiko Fujihara, Makoto Makishima, Daisuke Takahashi, Yukihiro Furusawa, Hiroki Kakuta, Koji Hase. A partial agonist for retinoid X receptor mitigates experimental colitis. International Immunology 2019; 31(4) doi: 10.1093/intimm/dxy089
2	Jayantha Arnold, Arvind Sangwaiya, Bharati Bhatkal, Frank Geoghegan, Mark Busbridge. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. European Journal of Gastroenterology & Hepatology 2009; 21(4) doi: 10.1097/MEG.0b013e32830e2885
3	J.K. Yamamoto-Furusho, G.E. Sánchez-Morales, D. García-Rangel, G. Vargas-Alarcón. Polimorfismos genéticos de interleucina-22 en pacientes con colitis ulcerosa. Revista de Gastroenterología de México 2016; 81(2) doi: 10.1016/j.rgmx.2016.02.002
4	Jesús K Yamamoto‐Furusho. Encyclopedia of Life Sciences. 2009; doi: 10.1002/9780470015902.a0021483
5	Ayane Mikami, Tasuku Ogita, Fu Namai, Suguru Shigemori, Takashi Sato, Takeshi Shimosato. Oral Administration of Flavonifractor plautii, a Bacteria Increased With Green Tea Consumption, Promotes Recovery From Acute Colitis in Mice via Suppression of IL-17. Frontiers in Nutrition 2021; 7 doi: 10.3389/fnut.2020.610946
6	Nallely Bueno-Hernández, Aarón Dominguez-López, Rafael Barreto-Zuñiga, Fausto Sánchez Muñoz, Jesús K. Yamamoto-Furusho. Quantification of low expressed SCD1 gene in colonic mucosa from patients with active ulcerative colitis. Inflammatory Bowel Diseases 2011; 17(12) doi: 10.1002/ibd.21856
7	Jesús K. Yamamoto-Furusho. Genetic Susceptibility in Inflammatory Bowel Disease. Clinical Reviews in Bone and Mineral Metabolism 2010; 8(3) doi: 10.1007/s12018-009-9068-0
8	Tatiana Sofía Rodríguez-Reyna, Cynthia Martínez-Reyes, Jesús Kazúo Yamamoto-Furusho. Rheumatic manifestations of inflammatory bowel disease. World Journal of Gastroenterology 2009; 15(44): 5517-5524 doi: 10.3748/wjg.15.5517 Abstract(1347) \| Core Tip(1165) \| Full Article(HTML)(12092) \| Full Article (PDF)-731K(860) \| Times Cited (79) \| Total Visits (13455) \| Open
9	Stephen B. Hanauer. Positioning biologic agents in the treatment of Crohnʼs disease. Inflammatory Bowel Diseases 2009; 15(10) doi: 10.1002/ibd.20918
10	Phani Krishna Kondamudi, Hemalatha Kovelamudi, Geetha Mathew, Pawan G. Nayak, Mallikarjuna C. Rao, Rekha R. Shenoy. Investigation of Sesamol on Myeloperoxidase and Colon Morphology in Acetic Acid-Induced Inflammatory Bowel Disorder in Albino Rats. The Scientific World Journal 2014; 2014 doi: 10.1155/2014/802701
11	Zane Straume, Nikola Krūmiņa, Ilze Elbere, Maija Rozenberga, Laura Blomniece, Renārs Erts, Dace Rudzīte, Jānis Kloviņš, Angelika Krūmiņa. Gut Microbiome Differences Regarding Lifestyle and the History of COVID-19 Disease in Ulcerative Colitis Patients. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2024; 78(4) doi: 10.2478/prolas-2024-0037
12	Titilayo Omolara Johnson, Augustina Oduje Akinsanmi, Stephen Adakole Ejembi, Olugbenga Eyitayo Adeyemi, Jane-Rose Oche, Grace Inioluwa Johnson, Abayomi Emmanuel Adegboyega. Modern drug discovery for inflammatory bowel disease: The role of computational methods. World Journal of Gastroenterology 2023; 29(2): 310-331 doi: 10.3748/wjg.v29.i2.310 Abstract(1561) \| Core Tip(1232) \| Full Article(HTML)(6212) \| Full Article (PDF)-2853K(618) \| Full Article (Word)-560K(86) \| Audio-1104K(23) \| Peer-Review Report-305K(177) \| Answering Reviewers-33K(189) \| Times Cited (21) \| Total Visits (8850) \| Open
13	Mohammad Reza Amini, Zeinab Khademi, Marieh Salavatizadeh, Niloufar Rasaei, Nasser Ebrahimi-Daryani, Ahmad Esmaillzadeh, Azita Hekmatdoost. The association between dietary patterns and disease severity in patients with ulcerative colitis. British Journal of Nutrition 2024; doi: 10.1017/S0007114524000187
14	Heidrun Potschka. Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport. Advanced Drug Delivery Reviews 2012; 64(10) doi: 10.1016/j.addr.2011.12.007
15	James McDermott, Areg Grigorian, Christian de Virgilio. Surgery. 2026; doi: 10.1007/978-3-032-09799-6_27
16	J.K. Yamamoto-Furusho. Evaluación del estado nutricional y su asociación con el grado de actividad en pacientes mexicanos con colitis ulcerosa crónica idiopática (CUCI). Revista de Gastroenterología de México 2021; 86(2) doi: 10.1016/j.rgmx.2020.08.004
17	J.K. Yamamoto-Furusho. Evaluation of nutritional status and its association with the grade of activity of ulcerative colitis in Mexican patients. Revista de Gastroenterología de México (English Edition) 2021; 86(2) doi: 10.1016/j.rgmxen.2020.08.003
18	Julien Grimoud, Henri Durand, Sarah de Souza, Pierre Monsan, Françoise Ouarné, Vassilia Theodorou, Christine Roques. In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. International Journal of Food Microbiology 2010; 144(1) doi: 10.1016/j.ijfoodmicro.2010.09.007
19	Wolfgang Mönch, Dagmar Breuker, Ute Middermann. Schmerzpsychotherapie. 2011; doi: 10.1007/978-3-642-12783-0_25
20	Sarath Sujatha-Bhaskar, Areg Grigorian, Christian de Virgilio. Surgery. 2020; doi: 10.1007/978-3-030-05387-1_27
21	May-Bente Bengtson, Camilla Solberg, Geir Aamodt, Jørgen Jahnsen, Bjørn Moum, Jostein Sauar, Morten H. Vatn. Clustering in time of familial IBD separates ulcerative colitis from Crohnʼs disease. Inflammatory Bowel Diseases 2009; 15(12) doi: 10.1002/ibd.20978
22	J.K. Yamamoto-Furusho, G.E. Sánchez-Morales, D. García-Rangel, G. Vargas-Alarcón. Genetic polymorphisms of interleukin-22 in patients with ulcerative colitis. Revista de Gastroenterología de México (English Edition) 2016; 81(2) doi: 10.1016/j.rgmxen.2016.02.006
23	Hai-Xia Shang, An-Qi Wang, Chun-Hui Bao, Huan-Gan Wu, Wei-Feng Chen, Lu-Yi Wu, Rong Ji, Ji-Meng Zhao, Yin Shi. Moxibustion combined with acupuncture increases tight junction protein expression in Crohn’s disease patients. World Journal of Gastroenterology 2015; 21(16): 4986-4996 doi: 10.3748/wjg.v21.i16.4986 Abstract(1749) \| Core Tip(1740) \| Full Article(HTML)(7667) \| Full Article (PDF)-1646K(932) \| Full Article (Word)-6303K(287) \| Peer-Review Report-91K(359) \| Answering Reviewers-58K(410) \| Times Cited (44) \| Total Visits (9860) \| Open
24	Heidrun Potschka. Modulating P‐glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies?. Epilepsia 2010; 51(8) doi: 10.1111/j.1528-1167.2010.02585.x
25	Nallely Bueno-Hernández, Fausto Sánchez-Muñoz, Rafael Barreto-Zuñiga, Aarón Dominguez-López, Jesús K. Yamamoto-Furusho. Expression of HNF4γ is downregulated in patients with active ulcerative colitis (UC) compared to UC patients in remission and healthy controls. Inflammatory Bowel Diseases 2011; 17(8) doi: 10.1002/ibd.21753
26	Nallely Bueno-Hernández, Martha Núñez-Aldana, Ilse Ascaño-Gutierrez, Jesús K Yamamoto-Furusho. Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire. Nutrition Journal 2015; 14(1) doi: 10.1186/s12937-015-0014-3
27	Michael Schultz, Anna Lisa Lindström. Rationale for probiotic treatment strategies in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2008; 2(3) doi: 10.1586/17474124.2.3.337